Modern Diagnostic & Research Centre Ltd.

BSE: 544673

SME

Sector: Healthcare

Industry Group: Healthcare Services

Industry: Healthcare Service Provider

51.00+0.0 (+0.00%)

26 Aug, 12:00 AM

Income Statement

Abridged

Understanding Income Statement

Modern Diagnostic & Research Centre Ltd. income statement covering revenue, operating profit, EBITDA, PAT and EPS across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31
	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31
Period length: Source:	12M PR	12M PR	12M PR	12M PR	12M PRESS
Total Revenue	60.21	56.28	67.13	77.95	83.11
Cost of Operating Revenue	24.94	21.39	21.56	23.00	26.80
Gross Profit	35.27	34.89	45.57	54.94	56.31
Gross Margin	58.6	62.0	67.9	70.5	67.8
Total Operating Expenses	57.88	61.14	60.00	64.17	75.71
Operating Profit	2.33	-4.86	7.13	13.77	7.40
Operating Margin	3.9	-8.6	10.6	17.7	8.9
Financing Income/(Expense) - Net	-1.19	-1.27	-1.78	-1.87	-2.44
Profit before Taxes	1.14	-5.94	6.86	12.72	5.99
Income Taxes	2.59	-0.21	1.07	3.76	0.74
Profit after Tax	-1.45	-5.73	5.79	8.97	5.25
PAT Margin	-2.4	-10.2	8.6	11.5	6.3
EPS - Basic - ex Extraordinary Items	-0.96	-3.80	3.84	5.94	3.48
EPS - Diluted - ex Extraordinary Items	-0.96	-3.80	3.84	5.94	3.48
EBIT	2.33	-4.86	7.13	13.77	7.40
EBITDA	5.99	-0.99	11.05	17.96	12.59
EBITDA Margin	9.9	-1.8	16.5	23.0	15.1

Balance Sheet

Abridged

Understanding Balance Sheet

Modern Diagnostic & Research Centre Ltd. balance sheet covering assets, liabilities, equity and borrowings across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	2022 Mar 31	2023 Mar 30	2024 Mar 31	2025 Mar 31	2026 Mar 31
	2022 Mar 31	2023 Mar 30	2024 Mar 31	2025 Mar 31	2026 Mar 31
Source:	PR	PR	PR	PR	PRESS
Total Current Assets	17.89	12.26	18.05	23.83	43.35
Long-Term Investments	5.29	0.11	0.21	0.23	16.97
Property Plant & Equipment - Net	24.27	23.64	26.24	29.67	46.52
Total Non-Current Assets	30.81	24.28	31.43	40.74	75.25
Total Assets	48.70	36.54	49.49	64.57	118.60
Total Current Liabilities	20.50	21.18	24.03	31.92	43.44
Long Term Debt	13.24	5.81	10.14	8.30	13.87
Total Non-Current Liabilities	16.50	9.39	13.69	11.93	16.61
Total Liabilities	37.00	30.58	37.73	43.85	60.05
Total Shareholders' Equity	11.70	5.96	11.76	20.73	58.55
Total Equity	11.70	5.96	11.76	20.73	58.55
Total Liabilities & Equity	48.70	36.54	49.49	64.57	118.60

Cash Flow

Abridged

Understanding Cash Flow Statement

Modern Diagnostic & Research Centre Ltd. cash flow statement covering operating, investing and financing activities across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31
	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31
Period length: Source:	12M PR	12M PR	12M PR	12M PR	12M PRESS
Operating CF bef Changes in Working Cap	4.82	-2.14	10.86	16.91	11.18
Working Capital - Increase/(Decrease)	-2.25	0.73	-4.69	-5.00	-9.64
Net CF from Operating Activities	2.57	-1.41	6.17	11.91	1.53
Capital Expenditures - Net	5.13	3.16	10.97	13.15	23.69
Net CF from Investing Activities	-5.56	2.02	-11.06	-13.17	-40.44
Stock - Issuance/(Retirement) - Net	-	-	-	-	32.52
Debt - LT & ST - Issuance/(Retirement) - Total	5.93	-5.09	5.15	1.64	15.00
Net Cash Flow from Financing Activities	5.93	-5.09	5.15	1.64	47.52
Free Cash Flow to Equity	3.38	-9.66	0.35	0.39	-7.16
Free Operating CF net dividend	-2.66	-4.75	-4.86	-1.25	-22.16
Free Operating CF	-2.66	-4.75	-4.86	-1.25	-22.16

Business Segment Analysis

Modern Diagnostic & Research Centre Ltd. business segment breakdown covering revenue, operating income and assets across key divisions for the selected financial year.

We don't have enough data to show business segment analysis for Modern Diagnostic & Research Centre Ltd.

Regional Segment Analysis

Modern Diagnostic & Research Centre Ltd. geographic revenue split showing domestic and international market performance across revenue and income for the selected financial year.

We don't have enough data to show regional segment analysis for Modern Diagnostic & Research Centre Ltd.

Historical Segment Analysis

Track how Modern Diagnostic & Research Centre Ltd. segment contributions have evolved over multiple financial years to see which divisions are growing, shrinking or gaining strategic importance.

We don't have enough data to show segments for Modern Diagnostic & Research Centre Ltd.

Frequently Asked Questions

What is the revenue of Modern Diagnostic & Research Centre Ltd.?

The latest trailing twelve month revenue of Modern Diagnostic & Research Centre Ltd. is ₹ 83.11 Cr, reflecting a 1-year growth of 6.63% and a 3-year CAGR of 13.88%. Annual and quarterly revenue trends are available in the Income Statement section.

What is the net profit of Modern Diagnostic & Research Centre Ltd.?

The latest trailing twelve month net profit (PAT) of Modern Diagnostic & Research Centre Ltd. is ₹ 5.25 Cr. Detailed profit history across annual and quarterly periods is in the Income Statement section.

What is the EBITDA of Modern Diagnostic & Research Centre Ltd.?

The trailing twelve month EBITDA of Modern Diagnostic & Research Centre Ltd. is approximately ₹ 7.40 Cr (based on an operating margin of 8.91%). EBITDA reflects core operating profitability before interest, taxes, depreciation and amortisation.

What is the EPS of Modern Diagnostic & Research Centre Ltd.?

The trailing twelve month Earnings Per Share (EPS) of Modern Diagnostic & Research Centre Ltd. is 3.48. EPS trends across annual and quarterly periods are visible in the Income Statement section.

What is the debt level of Modern Diagnostic & Research Centre Ltd.?

The debt-to-equity ratio of Modern Diagnostic & Research Centre Ltd. stands at 0.63. The interest coverage ratio is 3.03x, reflecting the company's ability to service debt from operating earnings. The full breakdown of total borrowings is in the Balance Sheet section.

What is the book value per share of Modern Diagnostic & Research Centre Ltd.?

The estimated book value per share of Modern Diagnostic & Research Centre Ltd. is 38.78 (derived from a P/B ratio of 1.32 and market price of ₹ 51.00), reflecting the net asset value attributable to each share. See the Balance Sheet section for a full breakdown.

What is the cash flow from operations of Modern Diagnostic & Research Centre Ltd.?

The trailing twelve month operating cash flow of Modern Diagnostic & Research Centre Ltd. is ₹ 1.53 Cr. Annual and quarterly cash flow data is available in the Cash Flow section of the Statements tab.

Does Modern Diagnostic & Research Centre Ltd. report consolidated or standalone financials?

Modern Diagnostic & Research Centre Ltd. reports consolidated financials. You can toggle between consolidated and standalone views using the switch at the top of each statement section.